Les parlementaires avaient voté fin 2023 des mesures qui devaient permettre la commercialisation de traitements à base de cannabis. Or, ces dispositions ne sont jamais entrées en vigueur, car elles nécessitent que le ministère de la santé en fasse officiellement part à la Commission européenne – ce qui a été fait mercredi.
The French government is advancing towards the general availability of medical cannabis, having taken a crucial administrative step by notifying the European Commission of the regulations for its production and authorization. This follows a period of experimentation and parliamentary votes in favor of commercialization, although obstacles remain, including debate over its benefits and potential reimbursement.
